Macrolide Pharmaceuticals
PrivateLast Round
Series B
Apr 2, 2018
Total Funding Raised
$42M
Company Overview
Macrolide Pharmaceuticals operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series B round in April 2018.
Macrolide Pharmaceuticals is a biotechnology company that develops novel, fully synthetic macrolide antibiotics to treat life-threatening, multi-drug resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Macrolide Pharmaceuticals Comparables
Compare Macrolide Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kinvard Bio | 83% | |
| smartbax GmbH | 80% | |
| MyxoBiomedical | 79% |
For institutional investors. Book with your work email.
Macrolide Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 2, 2018 | ||||
| Grant | Mar 1, 2018 | ||||
| Series A | Mar 4, 2015 |
For institutional investors. Book with your work email.
Macrolide Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series B, Series A |
| CARB-X | Grant |
| Gurnet Point Capital | Series A |
| SR One | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2018
$20M round with participation from Novartis and SR One.
- Mar 1, 2018
Received $2.44M in grant funding from CARB-X.
For institutional investors. Book with your work email.
Macrolide Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Macrolide Pharmaceuticals's valuation, stock price, and market status.
Is Macrolide Pharmaceuticals a public or private company?
Macrolide Pharmaceuticals is a private company.
What is the current stock price of Macrolide Pharmaceuticals?
Macrolide Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Macrolide Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Macrolide Pharmaceuticals worth (valuation)?
Valuation information for Macrolide Pharmaceuticals is not publicly available.
Can I buy Macrolide Pharmaceuticals stock?
Macrolide Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Macrolide Pharmaceuticals's last funding round?
Macrolide Pharmaceuticals's most recent funding round was Series B on April 2, 2018.
Who are the main investors in Macrolide Pharmaceuticals?
Key investors in Macrolide Pharmaceuticals include Roche Venture Fund, CARB-X, Gurnet Point Capital, SR One.
Will Macrolide Pharmaceuticals IPO soon?
No public IPO plans have been announced for Macrolide Pharmaceuticals.
How can I track Macrolide Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Macrolide Pharmaceuticals's shares on secondary markets.